Learn more about Robert Kennedy Jr. as he takes over as the Trump administration's Health and Human Services Secretary.

Secretary Robert F. Kennedy Jr. says he has a “generic list” of people he wants removed from his department. “I have a list ...

If a language can be used to build web scrapers, it definitely needs to provide a graceful data visualization library. --- by dongdong. In the Golang ecosystem, there are not many choices for data ...

A recent OIG report found that diagnoses reported in 2022 Medicare Advantage (MA) encounter data based only on health risk ...

A White House spokesperson denied to The Independent that there are any executive orders underway related to HHS, following ...

Bhaskar is a research assistant at the Program on Regulation, Therapeutics, and Law at Harvard Medical School. Kesselheim is a professor of medicine at Harvard Medical School and the director of ...

President Trump said he would take health agencies in a new direction on the campaign trail and has chosen some controversial nominees to help him achieve his goal, including Robert F. Kennedy Jr., ...

President Trump is withdrawing the U.S. from the World Health Organization. This increases our risk from severe infectious diseases by reducing the WHO’s ability to provide an early warning ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The memo, which was sent to agency leaders by acting HHS Secretary Dorothy Fink, outlines that the HHS agencies should refrain from sending any documents for publication in the Federal Register ...

Kennedy Jr., President-elect Donald Trump’s pick for HHS secretary, undergoes Senate confirmation. Kennedy’s confirmation hearings are still not scheduled, and he is facing bipartisan pressure ...

TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to ...